Counterion‐Engineered Water‐Stable Intravenously Administered Nanoparticles Enable In Vivo Reversal of Ticagrelor
Angewandte Chemie International Edition · 20.04.2026 · 65 (17)
DOI: 10.1002/anie.202523384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 10.03.2026. Verfasst von Wenchuang Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory For Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China. Hauptthemen laut MEDLINE: Ticagrelor, Water, Metal Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing New-Star Plan of Science and Technology.
Abstract (Originalsprache)
cis ‐Diols play critical roles in biological systems and form key structural motifs in many pharmaceuticals and vaccines. Specific in vivo recognition of a bioactive cis ‐diol and subsequent functional manipulation is thus desirable but remains challenging. Here, we present a boronic acid–functionalized gold nanoparticle (AuNP) platform that accomplishes this goal by uncovering the exceptional capacity of o ‐carborane decorated boronic acid to disrupt P2Y 12 ‐Ticagrelor binding and by highlighting the dual stabilizing roles of o ‐carboranyl via carbon ligation and B–H···Au chemisorption. Furthermore, by exploiting carborane‐derived counterions, we introduce a counterion‐engineering strategy that decouples water solubility from the chemical vulnerability of boronic acid. The resulting intravenous nanosystem selectively neutralizes Ticagrelor, a cis ‐diol–containing antiplatelet drug, with high efficacy demonstrated in both mouse and pig bleeding models. This work establishes the first chemical strategy for in vivo Ticagrelor reversal and offers a broadly applicable framework for diol targeting and nanomaterial design in complex biological environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory For Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, China.
- School of Nanoscience and Engineering, School of Chemical Sciences, University of Chinese Academy of Sciences, Beijing, China.
- College of Pharmacy, Beihua University, Jilin, China.
- School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, Hangzhou, China.
- Laboratory of Theoretical and Computational Nanoscience, National Center for Nanoscience and Technology, Beijing, China.
- College of Pharmaceutical Science, Jilin University, Changchun, China.
ORCID-Profile: Cen Tang
Förderung
- National Key Research and Development Program of China
- Beijing New-Star Plan of Science and Technology
Zitieren
APA
Yang, W., Tan, Y., Zheng, J., Liu, Y., Li, S., Gong, Y., Jiang, X., Zhang, S., Yang, K., Guo, X., Zheng, Q., Zhang, Y., & Tang, C. (2026). Counterion‐Engineered Water‐Stable Intravenously Administered Nanoparticles Enable In Vivo Reversal of Ticagrelor. Angewandte Chemie International Edition, 65(17). https://doi.org/10.1002/anie.202523384
Vancouver
Yang W, Tan Y, Zheng J, Liu Y, Li S, Gong Y, et al. Counterion‐Engineered Water‐Stable Intravenously Administered Nanoparticles Enable In Vivo Reversal of Ticagrelor. Angewandte Chemie International Edition. 2026;65(17). doi:10.1002/anie.202523384
BibTeX
@article{Yang2026,
author = {Yang, Wenchuang and Tan, Yabing and Zheng, Jiajia and Liu, Yang and Li, Shangze and Gong, Yue and Jiang, Xuan and Zhang, Shengye and Yang, Keshuang and Guo, Xiao and Zheng, Qiang and Zhang, Yinlong and Tang, Cen},
title = {Counterion‐Engineered Water‐Stable Intravenously Administered Nanoparticles Enable In Vivo Reversal of Ticagrelor},
journal = {Angewandte Chemie International Edition},
year = {2026},
volume = {65},
number = {17},
doi = {10.1002/anie.202523384}
}
EUVIMED